Early prediction of in-hospital death of COVID-19 patients: a machine-learning model based on age, blood analyses, and chest x-ray score

Abstract

An early-warning model to predict in-hospital mortality on admission of COVID-19 patients at an emergency department (ED) was developed and validate using a Machine-Learning model. In total, 2782 patients were enrolled between March 2020 and December 2020, including 2106 patients (first wave) and 676 patients (second wave) in the COVID-19 outbreak in Italy. The first-wave patients were divided into two groups with 1474 patients used to train the model, and 632 to validate it. The 676 patients in the second wave were used to test the model. Age, 17 blood analytes and Brescia chest X-ray score were the variables processed using a Random Forests classification algorithm to build and validate the model. ROC analysis was used to assess the model performances. A web-based death-risk calculator was implemented and integrated within the Laboratory Information System of the hospital. The final score was constructed by age (the most powerful predictor), blood analytes (the strongest predictors were lactate dehydrogenase, D-dimer, Neutrophil/Lymphocyte ratio, C-reactive protein, Lymphocyte %, Ferritin std and Monocyte %), and Brescia chest X-ray score. The areas under the receiver operating characteristic curve obtained for the three groups (training, validating and testing) were 0.98, 0.83 and 0.78, respectively. The model predicts in-hospital mortality on the basis of data that can be obtained in a short time, directly at the ED on admission. It functions as a web-based calculator, providing a risk score which is easy to interpret. It can be used in the triage process to support the decision on patient allocation.

Data availability

We are unable to share the dataset as it contains sensitive personal data collected during the pandemic at Spedali Civili di Brescia. We cannot share the full data since are data from patients. Interested researchers should contact the authors for any query related to data sharing and submit a project proposal Once defined the goal of the study, and the data needed authors will submit the potential project of collaboration to the IRB of Spedali Civili di Brescia to receive approval to access a deidentified dataset. Please note that other informations related to patients can be acquired, always following approoval of IRB of Spedali Civili di Brescia, not only the ones studied in the paper.Anyway, following request to the authors, it will be possible to share processed version of the dataset ( e.g. an Excel sheet with numbers used to plot the graphs and charts of the manuscript).All code used to analyse the data can be found on GitHub at https://github.com/biostatUniBS/BS_EWS

Article and author information

Author details

  1. Emirena Garrafa

    University of Brescia, Brescia, Italy
    For correspondence
    emirena.garrafa@unibs.it
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4761-6892
  2. Marika Vezzoli

    University of Brescia, Brescia, Italy
    Competing interests
    The authors declare that no competing interests exist.
  3. Marco Ravanelli

    University of Brescia, Brescia, Italy
    Competing interests
    The authors declare that no competing interests exist.
  4. Davide Farina

    University of Brescia, Brescia, Italy
    Competing interests
    The authors declare that no competing interests exist.
  5. Andrea Borghesi

    University of Brescia, Brescia, Italy
    Competing interests
    The authors declare that no competing interests exist.
  6. Stefano Calza

    University of Brescia, Brescia, Italy
    Competing interests
    The authors declare that no competing interests exist.
  7. Roberto Maroldi

    University of Brescia, Brescia, Italy
    Competing interests
    The authors declare that no competing interests exist.

Funding

Stefano Calza (PRIN 20178S4EK9)

  • Stefano Calza

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Human subjects: The Institutional review board aprpoved the study with the entry code NP4000.

Copyright

© 2021, Garrafa et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,016
    views
  • 135
    downloads
  • 23
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Emirena Garrafa
  2. Marika Vezzoli
  3. Marco Ravanelli
  4. Davide Farina
  5. Andrea Borghesi
  6. Stefano Calza
  7. Roberto Maroldi
(2021)
Early prediction of in-hospital death of COVID-19 patients: a machine-learning model based on age, blood analyses, and chest x-ray score
eLife 10:e70640.
https://doi.org/10.7554/eLife.70640

Share this article

https://doi.org/10.7554/eLife.70640

Further reading

    1. Biochemistry and Chemical Biology
    Luca Unione, Jesús Jiménez-Barbero
    Insight

    Glycans play an important role in modulating the interactions between natural killer cells and antibodies to fight pathogens and harmful cells.

    1. Biochemistry and Chemical Biology
    2. Cell Biology
    Kristina Ehring, Sophia Friederike Ehlers ... Kay Grobe
    Research Article

    The Sonic hedgehog (Shh) signaling pathway controls embryonic development and tissue homeostasis after birth. This requires regulated solubilization of dual-lipidated, firmly plasma membrane-associated Shh precursors from producing cells. Although it is firmly established that the resistance-nodulation-division transporter Dispatched (Disp) drives this process, it is less clear how lipidated Shh solubilization from the plasma membrane is achieved. We have previously shown that Disp promotes proteolytic solubilization of Shh from its lipidated terminal peptide anchors. This process, termed shedding, converts tightly membrane-associated hydrophobic Shh precursors into delipidated soluble proteins. We show here that Disp-mediated Shh shedding is modulated by a serum factor that we identify as high-density lipoprotein (HDL). In addition to serving as a soluble sink for free membrane cholesterol, HDLs also accept the cholesterol-modified Shh peptide from Disp. The cholesteroylated Shh peptide is necessary and sufficient for Disp-mediated transfer because artificially cholesteroylated mCherry associates with HDL in a Disp-dependent manner, whereas an N-palmitoylated Shh variant lacking C-cholesterol does not. Disp-mediated Shh transfer to HDL is completed by proteolytic processing of the palmitoylated N-terminal membrane anchor. In contrast to dual-processed soluble Shh with moderate bioactivity, HDL-associated N-processed Shh is highly bioactive. We propose that the purpose of generating different soluble forms of Shh from the dual-lipidated precursor is to tune cellular responses in a tissue-type and time-specific manner.